Intratect

Human Normal Immunoglobulin, the active ingredient in Intratect, is an immunoglobulin (IgG) presented as a sterile solution for intravenous use. It is indicated for immunoglobulin replacement therapy in patients with antibody deficiencies and is used to treat primary or secondary immunodeficiency, Kawasaki disease, and immune‑mediated thrombocytopenia.

GNH USA supplies Intratect as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and specialty clinics worldwide, ensuring quality, regulatory compliance, reliable cold‑chain logistics and dedicated technical support throughout global markets.

Intratect, an immunoglobulin replacement therapy, is used to restore antibody levels in several immune‑related conditions.

- Primary immunodeficiency diseases: restores IgG levels to reduce infection frequency. - Secondary immunodeficiency (e.g., chemotherapy, HIV): provides passive immunity to support compromised patients. - Kawasaki disease: reduces inflammation and prevents coronary artery complications. - Idiopathic thrombocytopenic purpura: modulates immune response to increase platelet counts.

Intratect may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Headache: mild to moderate pain in the head. - Fever: transient elevation of body temperature. - Chills: shaking sensations during or after infusion. - Fatigue: general tiredness post‑infusion. - Nausea: mild gastrointestinal upset. - Infusion‑related reactions: flushing, erythema, or mild hypotension.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate treatment. - Thromboembolic events: clot formation in vessels. - Acute renal failure: sudden loss of kidney function. - Aseptic meningitis: inflammation of meninges without infection. - Hemolysis: destruction of red blood cells. - Severe hypotension: marked drop in blood pressure.

Before initiating Intratect therapy, several precautions should be observed to ensure safety. - Assess baseline IgG levels: determine need for replacement. - Monitor for infusion reactions: observe vital signs during administration. - Adjust infusion rate if reactions occur: slow down or pause infusion. - Premedicate when indicated: use antihistamines or acetaminophen to reduce reactions. - Contraindicate in patients with severe IgA deficiency and anti‑IgA antibodies: risk of anaphylaxis. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Intratect can interact with other medicines, affecting safety or efficacy.

Major Interactions (Avoid): - Live vaccines: may cause uncontrolled infection due to immunosuppression. - Concurrent immunoglobulin products: risk of IgG overload. - Anticoagulants: increased bleeding risk from volume load. - ACE inhibitors: potential for additive hypotension. - Immunosuppressants: may diminish intended immune modulation.

Moderate Interactions (Monitor Closely): - Corticosteroids: may mask infusion reactions. - Diuretics: monitor fluid balance during infusion. - Antibiotics with nephrotoxic potential: watch renal function.